+36 30 779 1866 E-mail: info@biotalentum.hu

On 22 May, Prof. Dr. Andras Dinnyes gave a well-received talk in Paris at the 1st Innovations for Cell and Gene Therapies (ICGT) congress organized by MabDesign and SFTCG. In his talk, he addressed the versatility of the human iPSC-based platform, with a particular emphasis on the shift from antisense oligonucleotide therapy modelling to Type-1 diabetes beta-cell therapy. The conference gathered more than 180 participants, 20 speakers, and 17 sponsors/exhibitors who could exchange ideas on the latest developments in cell & gene therapies, the emerging technologies and the new preclinical models.